摘要
近年来,因多重耐药鲍曼不动杆菌造成的院内感染比例明显增加,其对常用的多种抗生素耐药,治疗困难和病死率高,已成为困扰临床医师的难题。在此回顾近年来关于多重耐药鲍曼不动杆菌的抗生素治疗文献,可用于临床治疗的抗生素有舒巴坦、多黏菌素、米诺环素、替加环素和利福平,鉴于这些抗生素临床较少应用,现探讨四种药物的特点和作用,期望为临床和研究提供帮助。
Multidrug-resistant Acinetobacter baumannii（MDR-Ab）leads to increased nosocomial infections proportion in recent years,which resisits to many common antibiotics and cause difficulties for treatment and high mortality.This article reviewed retrospectively recent literature regarding antibiotic treatment of MDR-Ab,the sulbactam,polymyxin B,minocycline,tigecycline and rifampicin are used in clinical treatment according to these reports.Since the four antibiotics are used occasionally in clinical experiences,we discuss the features and effects of these four antibiotics in this paper,which should be helpful to clinical experiences.
出处
《医学综述》
2010年第24期3781-3783,共3页
Medical Recapitulate
关键词
多重耐药鲍曼不动杆菌
抗生素
治疗
Multidrug-resistant Acinetobacter baumannii
Antibiotics
Treatment
